Structure of Everolimus
CAS No.: 159351-69-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Everolimus (RAD001) is a derivative of Rapamycin and a potent, selective, orally active mTOR1 inhibitor. It binds to FKBP-12 to form an immunosuppressive complex, inhibiting tumor cell proliferation, inducing cell apoptosis and autophagy, and exhibiting strong immunosuppressive and anticancer activities.
Synonyms: RAD001; SDZ-RAD; Certican
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Andressa Santana Santos ; Vinícius Alexandre Fiaia Costa ; Vivianny Aparecida Queiroz Freitas ; Laura Raniere Borges dos Anjos ; Eder Soares de Almeida Santos ; Thales Domingos Arantes , et al.
Abstract: Sporotrichosis is recognized as the predominant subcutaneous mycosis in South America, attributed to pathogenic species within the Sporothrix genus. Notably, in Brazil, Sporothrix brasiliensis emerges as the principal species, exhibiting significant sapronotic, zoonotic and enzootic epidemic potential. Consequently, the discovery of novel therapeutic agents for the treatment of sporotrichosis is imperative. The present study is dedicated to the repositioning of pharmaceuticals for sporotrichosis therapy. To achieve this goal, we designed a pipeline with the following steps: (a) compilation and preparation of Sporothrix genome data; (b) identification of orthologous proteins among the species; (c) identification of homologous proteins in publicly available drug-target databases; (d) selection of Sporothrix essential targets using validated genes from Saccharomyces cerevisiae; (e) molecular modeling studies; and (f) experimental validation of selected candidates. Based on this approach, we were able to prioritize eight drugs for in vitro experimental validation. Among the evaluated compounds, everolimus and bifonazole demonstrated minimum inhibitory concentration (MIC) values of 0.5 µg/mL and 4.0 µg/mL, respectively. Subsequently, molecular docking studies suggest that bifonazole and everolimus may target specific proteins within S. brasiliensis– namely, sterol 14-α-demethylase and serine/threonine-protein kinase TOR, respectively. These findings shed light on the potential binding affinities and binding modes of bifonazole and everolimus with their probable targets, providing a preliminary understanding of the antifungal mechanism of action of these compounds. In conclusion, our research advances the understanding of the therapeutic potential of bifonazole and everolimus, supporting their further investigation as antifungal agents for sporotrichosis in prospective hit-to-lead and preclinical investigations.
Show More >
Keywords: Sporotrichosis ; Sporothrix brasiliensis ; Drug repurposing ; Structural bioinformatics ; Everolimus
Show More >
Leclercq, Gabrielle ; Haegel, Hélène ; Toso, Alberto ; Zimmermann, Tina ; Green, Luke ; Steinhoff, Nathalie , et al.
Abstract: Background: T cell engaging therapies, like chimeric antigen receptor T cells and T cell bispecific antibodies (TCBs), efficiently redirect T cells towards tumor cells, facilitating the formation of a cytotoxic synapse and resulting in subsequent tumor cell killing, a process that is accompanied by the release of cytokines. Despite their promising efficacy in the clinic, treatment with TCBs is associated with a risk of cytokine release syndrome (CRS). The aim of this study was to identify small molecules able to mitigate cytokine release while retaining T cell-mediated tumor killing. Methods: By screening a library of 52 Food and Drug Administration approved kinase inhibitors for their impact on T cell proliferation and cytokine release after CD3 stimulation, we identified mTOR, JAK and Src kinases inhibitors as potential candidates to modulate TCB-mediated cytokine release at pharmacologically active doses. Using an in vitro model of target cell killing by human peripheral blood mononuclear cells, we assessed the effects of mTOR, JAK and Src kinase inhibitors combined with 2+1 T cell bispecific antibodies (TCBs) including CEA-TCB and CD19-TCB on T cell activation, proliferation and target cell killing measured by flow cytometry and cytokine release measured by Luminex. The combination of mTOR, JAK and Src kinase inhibitors together with CD19-TCB was evaluated in vivo in non-tumor bearing stem cell humanized NSG mice in terms of B cell depletion and in a lymphoma patient-derived xenograft (PDX) model in humanized NSG mice in terms of antitumor efficacy. Results: The effect of Src inhibitors differed from those of mTOR and JAK inhibitors with the suppression of CD19-TCB-induced tumor cell lysis in vitro, whereas mTOR and JAK inhibitors primarily affected TCB-mediated cytokine release. Importantly, we confirmed in vivo that Src, JAK and mTOR inhibitors strongly reduced CD19-TCB-induced cytokine release. In humanized NSG mice, continuous treatment with a Src inhibitor prevented CD19-TCB-mediated B cell depletion in contrast to mTOR and JAK inhibitors, which retained CD19-TCB efficacy. Ultimately, transient treatment with Src, mTOR and JAK inhibitors minimally interfered with antitumor efficacy in a lymphoma PDX model. Conclusions: Taken together, these data support further evaluation of the use of Src, JAK and mTOR inhibitors as prophylactic treatment to prevent occurrence of CRS.
Show More >
Purchased from AmBeed: 159351-69-6 ; 941678-49-5 ; 302962-49-8 ; 162635-04-3 ; 53123-88-9
Show More >
CAS No. : | 159351-69-6 |
Formula : | C53H83NO14 |
M.W : | 958.22 |
SMILES Code : | O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)\C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O |
Synonyms : |
RAD001; SDZ-RAD; Certican
|
MDL No. : | MFCD00929329 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
T47D | 100 nM | 6-12 months | Generate Everolimus-resistant cell lines and confirm their resistance | PMC10541180 |
MCF7 | 100 nM | 6-12 months | Generate Everolimus-resistant cell lines and confirm their resistance | PMC10541180 |
CAMA-1 | 50 nM | 6-12 months | Generate Everolimus-resistant cell lines and confirm their resistance | PMC10541180 |
LoVo cells | 10 nM, 100 nM, 1 µM | 72 h | To evaluate the effects of Everolimus on cell cycle, cell death, and autophagy in LoVo cells. Results showed that Everolimus had minor effects on LoVo cells. | PMC8531384 |
MDST8 cells | 10 nM, 100 nM, 1 µM | 72 h | To evaluate the effects of Everolimus on cell cycle, cell death, and autophagy in MDST8 cells. Results showed that Everolimus significantly inhibited MDST8 cell growth, induced cell cycle arrest, and autophagy. | PMC8531384 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Nude mice | MDST8 tumor model | Intraperitoneal injection | 4 mg/kg | Biweekly for 3 months | To evaluate the therapeutic effects of Everolimus on MDST8 tumors. Results showed that Everolimus significantly reduced MDST8 tumor volume and extended the lifespan of mice. | PMC8531384 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01462214 | Metastatic Renal Cell Cancer | PHASE1|PHASE2 | COMPLETED | 2025-01-17 | Medisch Centrum Alkmaar, Alkma... More >>ar, Netherlands|VU University Medical Center, Amsterdam, 1081 HV, Netherlands|NKI-AVL, Amsterdam, Netherlands|Haga Ziekenhuis, Den Haag, Netherlands|Medisch Centrum Haaglanden, Den Haag, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Spaarne Ziekenhuis Hoofddorp, Hoofddorp, Netherlands|Medisch Centrum Leeuwarden, Leeuwarden, Netherlands|University Hospital Maastricht, Maastricht, Netherlands|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|UMC St Radboud Nijmegen, Nijmegen, Netherlands|Sint Franciscus Gasthuis Rotterdam, Rotterdam, Netherlands|Isala Klinieken Zwolle, Zwolle, Netherlands Less << |
NCT00714025 | Transitional Cell Carcinoma | PHASE2 | COMPLETED | 2025-01-12 | Cliniques Universitaires St Lu... More >>c-UCL, Bruxelles, 1200, Belgium Less << |
NCT01734512 | Pediatric Recurrent Progressiv... More >>e Low-grade Gliomas|Pediatric Progressive Low-grade Gliomas Less << | PHASE2 | COMPLETED | 2024-07-31 | Children's Hospital Los Angele... More >>s, Los Angeles, California, 90027, United States|University of California, Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital Oakland, Oakland, California, 94609, United States|University of California, San Diego Rady Children's Hospital, San Diego, California, 92123, United States|University of California, San Francisco, San Francisco, California, 94158, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|University of Florida, Gainesville, Florida, 32611, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Johns Hopkins University, Baltimore, Maryland, 21218, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Children's Hospitals and Clinics of Minneapolis, Minneapolis, Minnesota, 55404, United States|St. Louis Children's Hospital, Washington University, Saint Louis, Missouri, 63130, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|The Children's Hospital Of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|University of Utah, Salt Lake City, Utah, 84112, United States|University of Washington, Seattle, Seattle, Washington, 98195, United States Less << |
NCT02236572 | Breast Cancer | PHASE2 | TERMINATED | 2021-03-01 | Yale University, New Haven, Co... More >>nnecticut, 06520, United States Less << |
NCT00457119 | Non Small Cell Lung Cancer | PHASE1 | COMPLETED | 2025-11-09 | Georgetown University/Lombardi... More >> Cancer Center StudyCoordinator:CRAD001C2114, Washington, District of Columbia, 20007-2197, United States|LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center, New Orleans, Louisiana, 70115, United States|U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office, Dallas, Texas, 75390-9151, United States|MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med. Onc., Houston, Texas, 77030-4009, United States|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Heidelberg, Victoria, 3084, Australia|Novartis Investigative Site, Essen, 45122, Germany|Novartis Investigative Site, Heidelberg, 69126, Germany Less << |
NCT01960829 | Melanoma|TOR Serine-Threonine ... More >>Kinases|Neoplasm Metastasis Less << | PHASE2 | UNKNOWN | - | LuSi, Beijing, Beijing, 100142... More >>, China Less << |
NCT02352844 | Solid Malignancy|Solid Tumor | PHASE2 | COMPLETED | 2017-08-15 | Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States Less << |
NCT01663805 | Delayed Function of Renal Tran... More >>splant Less << | PHASE4 | UNKNOWN | 2025-06-15 | Instituto de Urologia e Nefrol... More >>ogia, S?o José do Rio Preto, S?o Paulo, 15015-200, Brazil|Instituto de Urologia e Nefrologia, S?o José do Rio Preto, S?o Paulo, 15015-200, Brazil|Instituto de Urologia e Nefrologia, S?o José do Rio PReto, S?o Paulo, 15015200, Brazil Less << |
NCT00426049 | Coronary Artery Disease|Corona... More >>ry Restenosis Less << | PHASE3 | UNKNOWN | - | German Heart Institute Berlin,... More >> Berlin, 13353, Germany Less << |
NCT00170885 | Kidney Transplantation | PHASE4 | COMPLETED | 2025-07-07 | Novartis, Basel, Switzerland |
NCT00811590 | Peutz-Jeghers Syndrome | PHASE2 | TERMINATED | 2025-03-11 | Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less << |
NCT01152840 | Adenoid Cystic Carcinoma | PHASE2 | COMPLETED | 2025-12-12 | Seoul National University Hosp... More >>ital, Seoul, 110-744, Korea, Republic of Less << |
NCT00516165 | Hepatocellular Carcinoma | PHASE1|PHASE2 | COMPLETED | 2025-11-11 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States Less << |
NCT00466466 | Small-Cell Lung Cancer | PHASE1 | COMPLETED | - | Highlands Oncology Group, Faye... More >>tteville, Arkansas, 72703, United States|University of Colorado Health Sciences Center, Aurora, Colorado, 80045, United States|Dana Faber Cancer Institute, Boston, Massachusetts, 02115, United States|MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Paris, France Less << |
NCT00098241 | Kidney Transplantation | PHASE3 | COMPLETED | 2025-03-07 | Columbus Children's Hospital, ... More >>Columbus, Ohio, 43205-2696, United States|Dienst Pediatrie UZ Gasthuisberg, Herestraat 49, Leuven, 3000, Belgium Less << |
NCT00827359 | Renal Cell Carcinoma|Renal Can... More >>cer Less << | PHASE2 | COMPLETED | 2025-06-18 | Beth Israel Deaconess Medical ... More >>Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States Less << |
NCT01269684 | Kidney Transplantation | PHASE4 | WITHDRAWN | 2025-08-08 | Novartis Investigative Site, Z... More >>urich, Switzerland Less << |
NCT01167530 | Non-small Cell Lung Cancer|Loc... More >>ally Advanced Disease Less << | PHASE1 | UNKNOWN | 2025-07-14 | Institut Gustave Roussy, Ville... More >>juif, 94800, France Less << |
NCT00688623 | Advanced and Metastatic Silent... More >> Neuro-Endocrine Tumors|Carcinoma|Neuroendocrine|Non Functioning Neuroendocrine Tumors (NETs)|Non Syndromic Neuroendocrine Tumors|Carcinoids|Non Functioning Less << | PHASE2 | COMPLETED | 2016-11-07 | Novartis Investigative Site, B... More >>ordeaux, France|Novartis Investigative Site, Lyon, France|Novartis Investigative Site, Marseille, France|Novartis Investigative Site, Paris, France|Novartis Investigative Site, Bad Berka, 99438, Germany|Novartis Investigative Site, Bad Berka, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Bonn, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Munich, Germany|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Viagrande, CT, 95029, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Perugia, PG, 06129, Italy|Novartis Investigative Site, Roma, RM, 00189, Italy|Novartis Investigative Site, Bologna, Italy|Novartis Investigative Site, Milano, Italy|Novartis Investigative Site, Perugia, Italy|Novartis Investigative Site, Roma, Italy|Novartis Investigative Site, Viagrande, Italy|Novartis Investigative Site, Rotterdam, Netherlands|Novartis Investigative Site, Gdansk, 80-952, Poland|Novartis Investigative Site, Gdansk, Poland|Novartis Investigative Site, Warszawa, Poland|Novartis Investigative Site, Barcelona, Catalu?a, 08907, Spain|Novartis Investigative Site, Barcelona, Catalu?a, Spain|Novartis Investigative Site, Barcelona, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Uppsala, Spain|Novartis Investigative Site, Stockholm, Sweden|Novartis Investigative Site, Uppsala, SE-751 85, Sweden|Novartis Investigative Site, Glasgow - Scotland, G12 OYN, United Kingdom|Novartis Investigative Site, Glasgow, United Kingdom|Novartis Investigative Site, Manchester, M20 9BX, United Kingdom|Novartis Investigative Site, Manchester, United Kingdom Less << |
NCT02451696 | Epilepsy|Tuberous Sclerosis Co... More >>mplex|Focal Cortical Dysplasia Less << | PHASE2 | COMPLETED | 2017-12-28 | New York University Langone Me... More >>dical Center, New York, New York, 10016, United States Less << |
NCT00170859 | Heart Transplantation | PHASE4 | COMPLETED | 2025-12-06 | Novartis Investigational Site,... More >> Various Cities, Germany Less << |
NCT00655252 | Metastatic Renal Cell Cancer | NO_LONGER_AVAILABLE | - | Highlands oncology Group, PA, ... More >>Springdale, Arkansas, 72764, United States|University of Colorado Health Sciences Center/Anschutz Pavillion, Aurora, Colorado, 12801, United States|Cancer Centers of Florida, P.A., Ocoee, Florida, 34761, United States|MD Anderson Cancer Center - Orlando, Orlando, Florida, 32806, United States|Indiana University Cancer center, Indianapolis, Indiana, 46202, United States|The Cancer Institute, St. Joseph Medical Center, Towson, Maryland, 21209, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Missouri Cancer Associates, Columbia, Missouri, 65201, United States|Heartland Hematology-Oncology Associates, Inc., Kansas City, Missouri, 64118, United States|Washington University/Siteman Cancer Center, St. Louis, Missouri, 63110, United States|Blumenthal Cancer Center/Carolinas Medical Center, Charlotte, North Carolina, 28203, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States|Cliveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Cleo Craig Memorial Cancer & Research Clinic, Lawton, Oklahoma, 73505, United States|Cancer centers of the Carolinas, Greenville, South Carolina, 29615, United States|Novartis Investigative Site, Malvern, Australia|Novartis Investigative Site, Graz, Austria|Novartis Investigative Site, Linz, Austria|Novartis Investigative Site, Salzburg, Austria|Novartis Investigative Site, Vienna, Austria|Novartis Investigative Site, Brussels, Belgium|Moncton Hospital, Moncton, New Brunswick, E1C 6Z8, Canada|QE ll Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada|Royal Victoria Hospital, Barrie, Ontario, L4M 6M2, Canada|Lakeridhe Health Corp - Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Sault Area Hospital - General Site, Sault Ste Marie, Ontario, P6A 2C4, Canada|Les Urologues Associes du CHUM, Montreal, Quebec, H2X 1N8, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada|Saskatoon Cancer Center, Saskatoon, Saskatchewan, S7N 4H4, Canada|Novartis Investigative Site, Brno, Czech Republic|Novartis Investigative Site, Prague 2, Czech Republic|Novartis Investigative Site, Prague, Czech Republic|Novartis Investigative Site, Augsburg, Germany|Novartis Investigative Site, Bautzen, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Bremen, Germany|Novartis Investigative Site, Chemnitz, Germany|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Erlangen, Germany|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Frankfurt/Main, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Freiburg, Germany|Novartis Investigative Site, Fulda, Germany|Novartis Investigative Site, Goslar, Germany|Novartis Investigative Site, Hamburg, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Jena, Germany|Novartis Investigative site, Koln, Germany|Novartis Investigative Site, Leipzig, Germany|Novartis Investigative Site, Magdeburg, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Mannheim, Germany|Novartis Investigative Site, Munchen, Germany|Novartis Investigative site, Munster, Germany|Novartis Investidative Site, Nurnberg, Germany|Novartis Investigative Site, Offenburg, Germany|Novartis Investigative Site, Oldenburg, Germany|Novartis Investigative Site, Recklinghausen, Germany|Novartis Investigative Site, Rostock, Germany|Novartis Investigative Site, Tubingen, Germany|Novartis Investigative Site, Wuppertal, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Beirut, Lebanon|Novartis Investigative Site, Alesund, Norway|Novartis Investigative Site, Oslo, Norway|Novartis Investigative Site, Geneva, Switzerland|Novartis Investigative Site, St. Gallen, Switzerland|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Istanbul, Turkey|Novartis Investigative Site, Izmir, Turkey|Royal Bournemouth Hospital, Bournemouth, BH7 7DW, United Kingdom|British Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrookes Hospital, Cambridge, CB2 0QQ, United Kingdom|CRUK, Glasgow, G61 1BD, United Kingdom|Southampton University Hospital NHS Trust,, Hampshire, SO16 6YD, United Kingdom|Oncology & Haematology Clinical Tirals Unit, Leicester, LE1 5WW, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom|Guy's and St. Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|The Christie Hospital, Manchester, M20 9BX, United Kingdom|Newcastle General Hospital, Newcastle, NE4 6BE, United Kingdom|Mount Vernon Cancer Centre, Northwood, HA6 2RN, United Kingdom|St Luke's Wing, Royal Surrey County Hospital, Surrey, GU2 7XX, United Kingdom|Singleton Hospital, Swansea, SA2 8QA, United Kingdom Less << | |
NCT01609673 | End Stage Renal Failure With R... More >>enal Transplant Less << | TERMINATED | 2025-05-13 | Hospital S?o Jo?o de Deus/Fund... More >>a??o Geraldo Corrêa, Divinópolis, MG, 35500-227, Brazil|Hospital Márcio Cunha/Funda??o S?o Francisco Xavier, Ipatinga, MG, 35160-158, Brazil|Funda??o IMEPEN, Juiz de Fora, MG, 36036-330, Brazil|Hospital do Rim de MOntes Claros/Irmandade Nossa Senhora das Mercês, Montes Claros, MG, 39400-103, Brazil Less << | |
NCT02338609 | Growth and Development | PHASE4 | COMPLETED | 2023-12-18 | University Of California LA SC... More >>, Los Angeles, California, 90095, United States|Minnesota Epilepsy Group, Saint Paul, Minnesota, 55102, United States|Cinn Children Hosp Medical Center SC, Cincinnati, Ohio, 45229-3039, United States|Texas Scottish Rite Hos for Child SC, Dallas, Texas, 75219, United States|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Moscow, 127412, Russian Federation Less << |
NCT03493165 | Uterine Sarcoma | AVAILABLE | - | - | |
NCT01059318 | Lymphangioleiomyomatosis | PHASE2 | COMPLETED | 2025-06-12 | Center for LAM Research and Cl... More >>inical Care, Boston, Massachusetts, 02115, United States|University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine,, Cincinnati, Ohio, 45267, United States|Novartis Investigative Site, Lyon, France|Novartis Investigative Site, Milan, Italy Less << |
NCT01482299 | Stomach Neoplasm | PHASE2 | COMPLETED | 2025-01-14 | Asan Medical Center, Songpa-gu... More >>, Seoul, Korea, Republic of Less << |
NCT01491672 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE2 | COMPLETED | 2025-05-15 | Memorial Sloan Kettering Cance... More >>r Center, NY, New York, 90033, United States|Novartis Investigative Site, Rio Negro, Viedma, 8500, Argentina|Novartis Investigative Site, Tucuman, T4000, Argentina|Novartis Investigative Site, Florianopolis, SC, 88034-000, Brazil|Novartis Investigative Site, Barretos, SP, 14784-400, Brazil|Novartis Investigative Site, S?o Paulo, SP, 01246-000, Brazil|Novartis Investigative Site, S?o Paulo, SP, 01509-900, Brazil|Novartis Investigative Site, Sofia, 1784, Bulgaria|Novartis Investigative Site, Beijing, Beijing, 100730, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310003, China|Novartis Investigative Site, Beijing, 100021, China|Novartis Investigative Site, Guangzhou, 510060, China|Novartis Investigative Site, Shanghai, 200032, China|Novartis Investigative Site, Leningrad Region, Russia, 188663, Russian Federation|Novartis Investigative Site, Moscow, Russia, 125284, Russian Federation|Novartis Investigative Site, Nizhny Novgorod, Russia, 603001, Russian Federation|Novartis Investigative Site, Obninsk, Russia, 249036, Russian Federation Less << |
NCT01509560 | Condition After Allogenic Peri... More >>pheral Stem Cell Transplantation (SCT) Less << | PHASE2 | COMPLETED | 2016-04-30 | Zentrum für Knochenmark- und B... More >>lutstammzelltransplantation,, Wiesbaden, Hessen, 65191, Germany Less << |
NCT01566279 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | COMPLETED | 2025-11-16 | NKI-AVL, Amsterdam, Noord Holl... More >>and, 1066 CX, Netherlands|Erasmus Medical Center, Rotterdam, Zuid Holland, 3075 EA, Netherlands|University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands Less << | |
NCT00446368 | Carcinoma, Renal Cell | PHASE2 | COMPLETED | 2025-10-08 | Baylor College of Medicine - M... More >>ethodist Hospital, Houston, Texas, 77030, United States Less << |
NCT02809404 | Breast Cancer|Renal Cell Carci... More >>noma Less << | COMPLETED | 2025-01-17 | Radboud university medical cen... More >>ter, Nijmegen, Netherlands Less << | |
NCT01216839 | Refractory or Relapsed RMS and... More >> Soft Tissue Sarcomas Less << | PHASE2 | UNKNOWN | 2025-12-13 | Casa de Saúde Santa Marcelina,... More >> Sao Paulo, SP, 08270070, Brazil Less << |
NCT01637090 | Cutaneous T-Cell Lymphoma | PHASE2 | TERMINATED | 2025-05-15 | Boston Medical Center, Boston,... More >> Massachusetts, 02118, United States Less << |
NCT00702052 | Lymphoma, Mantle- Cell | PHASE2 | COMPLETED | 2012-04-20 | Mayo Clinic - Arizona Mayo Cli... More >>nic - Scottsdale, Multiple Locations, Arizona, 85259, United States|Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville, Arkansas, 72703, United States|Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord, California, 94520, United States|City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte, California, 91010-3000, United States|UCLA/ University of California Los Angeles Dept.of Hem/Oncology, Los Angeles, California, 90095, United States|University of California Davis Cancer Center Dept. of UC Davis Cancer (4), Sacramento, California, 95817, United States|Rocky Mountain Cancer Centers RMCC - Denver-Midtown, Greenwood Village, Colorado, 80121, United States|Advanced Medical Specialties Medical Onc Hem, Miami, Florida, 33176, United States|Georgia Health Sciences University Dept. of MCG, Augusta, Georgia, 30912, United States|Northwestern University, Chicago, Illinois, 60611, United States|St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2), Beech Grove, Indiana, 46107, United States|Central Indiana Cancer Centers CICC - East (2), Indianapolis, Indiana, 46227, United States|University of Michigan Comprehensive Cancer Center Dept of Michigan Cancer Center, Ann Arbor, Michigan, 48109-0944, United States|Mayo Clinic - Rochester Hematology, Rochester, Minnesota, 55905, United States|Washington University School Of Medicine-Siteman Cancer Ctr Medical Oncology, Saint Louis, Missouri, 63110, United States|Hackensack University Medical Center Dept ofHackensackUniversityMC, Hackensack, New Jersey, 07601, United States|New York University Medical Center NYU Cancer Institute, New York, New York, 10016, United States|East Carolina University BrodySchool of Medicine, Greenville, North Carolina, 27858, United States|Northwest Cancer Specialists Vancouver Cancer Center (2), Portland, Oregon, 97210, United States|Kaiser Permanente Northwest Dept of Kaiser Northwest (3), Portland, Oregon, 97227, United States|Fox Chase Cancer Center Regulatory Contact, Philadelphia, Pennsylvania, 19111-2497, United States|Western Pennsylvania Cancer Institute /Western Penn Hospital Western Pann. Cancer Inst., Pittsburgh, Pennsylvania, 15224, United States|University of Pittsburgh Medical Center Hillman Cancer Center (4), Pittsburgh, Pennsylvania, 15232, United States|Cancer Centers of the Carolinas CC of C -Eastside, Greenville, South Carolina, 29605, United States|Vanderbilt University Medical Center, Clinical Trials Center Dept. of VUMC, Nashville, Tennessee, 37212, United States|Baylor College of Medicine Dept. of Sammons Cancer (2), Dallas, Texas, 75246, United States|University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(2), Dallas, Texas, 75390-8527, United States|MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (10), Houston, Texas, 77030-4009, United States|Tyler Cancer Center Dept.ofTylerCancerCtr., Tyler, Texas, 75702, United States|Cancer Care Northwest CC Northwest- Spokane South(3), Spokane, Washington, 99202, United States|West Virginia University/ Mary Babb Randolph Cancer Center, Morgantown, West Virginia, 26506, United States Less << |
NCT00401778 | Lung Cancer | PHASE1 | COMPLETED | 2025-12-13 | Emory University Winship Cance... More >>r Institute, Atlanta, Georgia, 30322, United States Less << |
NCT00529802 | Carcinoma, Renal Cell | PHASE2 | COMPLETED | 2025-07-10 | University of Chicago, Chicago... More >>, Illinois, 60637, United States|Oncology/Hematology Associates, Peoria, Illinois, 61615, United States|Beth Israel Deaconess Med Ctr, Boston, Massachusetts, 02215, United States|Washington University, Saint Louis, Missouri, 63110, United States|The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States Less << |
NCT01239472 | Renal Transplant Rejection|Imm... More >>unosuppression Less << | PHASE4 | COMPLETED | 2025-06-15 | Santa Casa de Misericórdia de ... More >>Belo Horizonte, Belo Horizonte, Minas Gerais, 30150221, Brazil Less << |
NCT02332902 | Neurofibromatosis 1 | PHASE2 | COMPLETED | 2025-03-16 | The University of Texas Health... More >> Science Center at Houston, Houston, Texas, 77030, United States Less << |
NCT01514110 | Gastric Cancer | PHASE1|PHASE2 | COMPLETED | 2019-03-06 | Department of Clinical Oncolog... More >>y, Prince of Wales Hospital, Hong Kong, Hong Kong Less << |
NCT00629525 | Hormone Refractory Prostate Ca... More >>ncer Less << | PHASE2 | COMPLETED | 2025-01-10 | Duke University MEdical Center... More >>, Durham, North Carolina, 27710, United States Less << |
NCT00976248 | Waldenstrom's Macroglobulinemi... More >>a Less << | PHASE2 | COMPLETED | 2025-07-18 | Dana-Farber Cancer Institute, ... More >>Boston, Massachusetts, 02115, United States Less << |
NCT01653041 | Kidney Transplantation | PHASE4 | COMPLETED | 2025-04-15 | Hospital do Rim e Hipertens?o,... More >> S?o Paulo, 04038-002, Brazil Less << |
NCT01216826 | Refractory or Relapsed Osteosa... More >>rcoma Less << | PHASE2 | UNKNOWN | 2025-12-14 | Hospital Santa Marcelina, Sao ... More >>Paulo, SP, 08270070, Brazil Less << |
NCT00087685 | Endometrial Cancer | PHASE2 | COMPLETED | 2025-01-15 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
NCT01830153 | Soft Tissue Sarcomas|Bone Sarc... More >>omas Less << | PHASE2 | COMPLETED | - | Seoul National University Bund... More >>ang Hospital, Seongnam, Gyeonggi, 463-707, Korea, Republic of|Asan Medical Center, University of Ulsan College of Medicine, Seoul, N/A = Not Applicable, 138-736, Korea, Republic of|Yeongnam University College of Medicine, Daegu, Korea, Republic of|Chungnam National University Hospital, Daejeon, 301-721, Korea, Republic of|Seoul National University Hospital, Seoul, 110-744, Korea, Republic of|Yonsei Cancer Center, Seoul, 120-752, Korea, Republic of|Korea University, Seoul, 126-1, Korea, Republic of|Samsung Medical Center, Seoul, 135-710, Korea, Republic of Less << |
NCT00150046 | Heart Transplantation | PHASE3 | COMPLETED | - | Novartis Investigational Site,... More >> Germany, Germany|Basel Novartis Pharma AG, Basel, Switzerland Less << |
NCT01594268 | Kidney Transplant | PHASE4 | COMPLETED | 2025-10-13 | Novartis Investigative Site, S... More >>eoul, Korea, 120-752, Korea, Republic of|Novartis Investigative Site, Seoul, 135-720, Korea, Republic of|Novartis Investigative Site, Seoul, 738-736, Korea, Republic of|Novartis Investigative Site, Suwon, 442-721, Korea, Republic of Less << |
NCT01070316 | Epilepsy|Tuberous Sclerosis Co... More >>mplex Less << | PHASE1|PHASE2 | COMPLETED | 2025-04-16 | Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States|Baylor College of Medicine, Houston, Texas, 77030, United States Less << |
NCT00505102 | Kidney Diseases|Heart Transpla... More >>ntation Less << | PHASE4 | UNKNOWN | 2025-07-09 | Heart Transplant Center Ospeda... More >>li Riuniti, Bergamo, 24100, Italy|Heart Transplantad Center OspedaliRiuniti Bergamo, Bergamo, 24100, Italy Less << |
NCT00805129 | Bladder Cancer|Metastatic Tran... More >>sitional Cell Carcinoma Less << | PHASE2 | COMPLETED | 2021-12-15 | Memorial Sloan Kettering Cance... More >>r Center, New York, New York, 10065, United States Less << |
NCT02017860 | Neoplasms | PHASE2 | COMPLETED | 2019-04-25 | Novartis Investigative Site, M... More >>atsuyama, Ehime, 791-0280, Japan|Novartis Investigative Site, Sapporo city, Hokkaido, 060 8648, Japan|Novartis Investigative Site, Osaka-city, Osaka, 540-0006, Japan|Novartis Investigative Site, Kitaadachi-gun, Saitama, 362-0806, Japan Less << |
NCT00936858 | Thyroid Cancer | PHASE2 | COMPLETED | 2020-02-27 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Mt. Sinai Medical Center, New York, New York, 10029, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States Less << |
NCT00170833 | Renal Transplantation | PHASE3 | COMPLETED | - | - |
NCT00729482 | Stomach Neoplasm | PHASE2 | COMPLETED | 2025-03-13 | Asan Medical Center, Seoul, So... More >>ngpa, 138-736, Korea, Republic of Less << |
NCT01888042 | Kidney Cancer | PHASE2 | TERMINATED | 2025-07-14 | Gustave Roussy, Villejuif, Val... More >> de Marne, 94805, France Less << |
NCT00968591 | Hepatic Insufficiency | PHASE1 | COMPLETED | - | Novartis Investigative Site, F... More >>rankfurt, Germany|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Singapore, Singapore Less << |
NCT00411619 | Tuberous Sclerosis|Subependyma... More >>l Giant Cell Astrocytoma Less << | PHASE1|PHASE2 | COMPLETED | 2025-01-14 | Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less << |
NCT02504892 | Renal Cancer|Birt-Hogg-Dube Sy... More >>ndrome Less << | PHASE2 | TERMINATED | 2018-04-17 | National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less << |
NCT01152827 | Pheochromocytoma|Extra-adrenal... More >> Paraganglioma|Non-functioning Carcinoid Less << | PHASE2 | COMPLETED | 2025-12-11 | Seoul National University Hosp... More >>ital, Seoul, 110-744, Korea, Republic of Less << |
NCT00799188 | Cardiac Transplantation|Skin C... More >>ancer Less << | PHASE3 | UNKNOWN | - | HOSPICES CIVILS de LYON, Lyon,... More >> France Less << |
NCT00337545 | Colorectal Cancer | PHASE2 | COMPLETED | 2025-04-07 | Swedish Cancer Institute, Seat... More >>tle, Washington, 98104, United States Less << |
NCT03955172 | Kidney Transplant Failure and ... More >>Rejection Less << | RECRUITING | 2027-12-03 | Service de transplantation, né... More >>phrologie et immunologie clinique, H?pital Edouard Herriot (HCL), Lyon, 69003, France Less << | |
NCT00830895 | Renal Cell Carcinoma | PHASE2 | COMPLETED | 2025-12-12 | Seoul National University Hosp... More >>ital, Seoul, Korea, Republic of Less << |
NCT02201212 | TSC1|TSC2|Tuberous Sclerosis C... More >>omplex|MTOR Less << | PHASE2 | COMPLETED | 2025-06-19 | Dana Farber Cancer Institute, ... More >>Boston, Massachusetts, 02115, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States Less << |
NCT01525719 | Cholangiocarcinoma | PHASE2 | UNKNOWN | 2025-06-14 | - |
NCT02056587 | Metastatic Renal Cell Carcinom... More >>a Less << | PHASE4 | COMPLETED | 2025-10-13 | Tatarstan Regional Cancer Cent... More >>er, Kazan, Tatarstan, 420029, Russian Federation|Altai Regional Cancer Center, Barnaul, Russian Federation|N.N. Blokhin Russian Cancer Research Center, Moscow, 115478, Russian Federation Less << |
NCT02569125 | Segmental Overgrowth Syndrome | PHASE2 | WITHDRAWN | 2025-02-16 | Vivantes Klinikum Neuk?lln, Be... More >>rlin, 12351, Germany|Universit?tsklinikum Bonn, Bonn, 53113, Germany|Universit?tsklinikum Freiburg, Freiburg, 79106, Germany|Universit?tsklinikum Leipzig, Leipzig, 04103, Germany Less << |
NCT02273752 | Estrogen Receptor-positive Bre... More >>ast Cancer|Gastrinoma|Glucagonoma|HER2-negative Breast Cancer|Insulinoma|Mucositis|Oral Complications|Pancreatic Polypeptide Tumor|Progesterone Receptor-positive Breast Cancer|Recurrent Breast Cancer|Recurrent Islet Cell Carcinoma|Recurrent Renal Cell Cancer|Somatostatinoma|Stage III Renal Cell Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Renal Cell Cancer Less << | PHASE2 | TERMINATED | 2025-12-15 | Emory University Hospital Midt... More >>own, Atlanta, Georgia, 30308, United States|Emory University/Winship Cancer Institute, Atlanta, Georgia, 30322, United States Less << |
NCT04867720 | Liver Transplant | PHASE4 | UNKNOWN | 2023-02-22 | Seoul National University Hosi... More >>pital, Seoul, Korea, Republic of Less << |
NCT03493152 | Gastrointestinal Stromal Tumor | TEMPORARILY_NOT_AVAILABLE | - | - | |
NCT01648465 | Gastrointestinal Tumors|Pancre... More >>atic Tumors|Gastrointestinal Neuroendocrine Tumors|Pancreatic Neuroendocrine Tumors Less << | PHASE2 | TERMINATED | 2019-08-06 | 2nd Dept of Internal Medicine,... More >> Agios Savvas Cancer Hospital, Athens, 11522, Greece|Dept of Medical Oncology, 251 General Airforce Hospital, Athens, 11525, Greece|2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio", Athens, 11527, Greece|2nd Dept of Internal Medicine, Propaedeutic, University Hospital "Attikon", Athens, 12462, Greece|4th Dept of Internal Medicine, University Hospital "Attiko", Athens, 12462, Greece|3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, 14564, Greece|2nd Dept of Medical Oncology, Metropolitan Hospital, Athens, 18547, Greece|Dept of Medical Oncology, University Hospital of Heraklion, Heraklion, 71110, Greece|Dept of Medical Oncology, Ioannina University Hospital, Ioannina, 45110, Greece|Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Patra, 26504, Greece|Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki, 56429, Greece|Dept of Medical Oncology, Thermi Clinic, Thessaloniki, 57001, Greece Less << |
NCT01088893 | Breast Neoplasms | PHASE2 | UNKNOWN | 2025-03-13 | Unimed Medical Institute, Hong... More >> Kong, China Less << |
NCT01561404 | Disorder Related to Renal Tran... More >>splantation|Exercise, Aerobic|Muscle Strength Less << | PHASE4 | TERMINATED | 2025-12-13 | Nephrology Department. Hospita... More >>l Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelone, 08907, Spain Less << |
NCT01636466 | Kidney Failure, Chronic | PHASE3 | TERMINATED | 2025-05-14 | Emory University, Atlanta, Geo... More >>rgia, 30322, United States Less << |
NCT01164267 | Marginal Zone B-cell Lymphoma | PHASE2 | COMPLETED | - | General Hospital AKH, Vienna, ... More >>Austria|Policlinico S. Orsola Malpighi, Bologna, Italy|IEO, Milano, Italy|INT, Milano, Italy|Humanitas, Milan, Italy|San Raffaele Hospital, Milan, Italy|AOU Maggiore della Carità, Novara, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy|AOU S. Giovanni Battista, Torino, Italy|IOSI, Bellinzona, Switzerland Less << |
NCT01009957 | Polycystic Kidney Diseases | PHASE2|PHASE3 | TERMINATED | 2025-06-15 | A.O. Spedali Civili Di Brescia... More >>, Brescia, Italy|Alessandro Manzoni Hospital, Nephrology and Dialysis Department, Lecco, 23900, Italy|Modena Hospital, Modena, 41100, Italy|Dipartimento di Patologia Sistematica - Università Federico 2°, Napoli, 80138, Italy|Ospedale "Guglielmo da Saliceto" - Nephrology and Dialysis Department, Piacenza, 29100, Italy|C.M.I.D. - Presidi Ospedalieri ASL 4, Torino, 10152, Italy|Ospedale Civile San Bortolo Vicenza, Vicenza, Italy Less << |
NCT03629847 | Neuroendocrine Tumors | PHASE1|PHASE2 | UNKNOWN | 2025-12-18 | Oncology Centre, King Faisal S... More >>pecialist Hospital & Research Center, Riyadh, 11211, Saudi Arabia Less << |
NCT00187174 | Tumors|Brain Tumors|Rhabdomyos... More >>arcoma|Sarcoma, Soft Tissue Less << | PHASE1 | COMPLETED | 2025-10-08 | St. Jude Children's Research H... More >>ospital, Memphis, Tennessee, 38105, United States Less << |
NCT01399242 | Disorder Related to Renal Tran... More >>splantation Less << | PHASE4 | UNKNOWN | 2025-06-13 | Hospital Universitário S?o Jos... More >>é, Belo Horizonte, Minas Gerais, 30140-073, Brazil Less << |
NCT02493465 | Left Ventricular Hypertrophy | PHASE4 | UNKNOWN | 2025-07-17 | Instituto de Urologia e Nefrol... More >>ogia, S?o José do Rio Preto, S?o Paulo, 15015-200, Brazil Less << |
NCT02049047 | Thymoma and Thymic Carcinoma | PHASE2 | COMPLETED | 2025-01-19 | Istituto Clinico Humanitas, Ro... More >>zzano, MI, 20089, Italy Less << |
NCT01423708 | Liver Failure|Liver Diseases|L... More >>iver Cirrhosis|Liver Neoplasms Less << | PHASE2 | UNKNOWN | 2025-01-14 | Ospedali Riuniti - Bergamo, Be... More >>rgamo, BG, 24128, Italy|Irccs Ospedale Maggiore Policlinico Di Milano, Milano, MI, 20122, Italy|Ospedale Ca' Granda-Niguarda - Milano, Milano, MI, 20162, Italy|Azienda Ospedaliera di Padova, Padua, PD, 35128, Italy|Policlinico Universitario Gemelli Di Roma, Roma, RM, 00168, Italy|A.O. Universitaria S. Giovanni Battista-Molinette Di Torino, Torino, TO, 10126, Italy|A.O. Universitaria S. Maria Della Misericordia Di Udine, Udine, UD, 33100, Italy Less << |
NCT01266837 | Metastatic Renal Cell Carcinom... More >>a|Failure of Exactly One Prior VEGF-targeted Therapy Less << | PHASE4 | COMPLETED | 2017-10-31 | Charitè Campus Benjamin Frankl... More >>in, Berlin, 12203, Germany|Klinik und Poliklinik für Urologie , Universit?tsklinikum Carl Gustav Carus der Technischen Universit?t Dresden, Dresden, 01307, Germany|Urologie - Waldkrankenhaus St. Marien, Erlangen, 91054, Germany|Klinik für Innere Medizin (Tumorforschung), Universit?tsklinikum Essen, Essen, 45122, Germany|Zentrum Innere Medizin, Medizinische Hochschule Hannover, Hannover, 30625, Germany|Klinik für Urologie und Kinderurologie, Universit?tsklinikum des Saarlandes, Homburg, 66421, Germany|Klinik für Urologie, Universit?tsklinikum Jena, Jena, 07743, Germany|5. Medizinische Klinik, Klinikum Nürnberg, Nürnberg, 90419, Germany Less << |
NCT01466231 | Germ Cell Tumor | PHASE2 | COMPLETED | 2025-06-15 | National Cancer Institute, Bra... More >>tislava, 83310, Slovakia Less << |
NCT00409292 | Pancreatic Cancer | PHASE2 | COMPLETED | 2025-05-09 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less << |
NCT00657982 | Prostate Cancer | PHASE2 | UNKNOWN | - | Sheba Medical Center, Tel Hash... More >>omer, 52621, Israel Less << |
NCT02155920 | Recurrent Childhood Ependymoma | PHASE2 | COMPLETED | 2023-07-14 | Lucile Packard Children's Hosp... More >>ital Stanford University, Stanford, California, 94305, United States|New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders, New York, New York, 10016, United States|UT Southwestern Medical Center / Children's Medical Center, Dallas, Texas, 75390, United States|Baylor College of Medicine / Texas Children's Hospital, Houston, Texas, 77030, United States Less << |
NCT02338570 | Renal Cell Carcinoma | PHASE4 | TERMINATED | 2025-02-18 | Spedali Civili, Brescia, Italy... More >>|Ospedale A Perrino, Brindisi, Italy|Istituto Europeo di Oncologia, Milano, Italy|Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, Napoli, Italy|AOU Maggiore della Carità, Novara, Italy|Casa di Cura La Maddalena, Palermo, Italy|Unicampus Biomedico, Roma, Italy|AOU San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy Less << |
NCT01048723 | Sarcoma | PHASE2 | TERMINATED | 2025-10-11 | H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612, United States Less << |
NCT02687958 | Neuroendocrine Carcinoma | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-12-23 | S.C. Oncologia - Policlinico, ... More >>Modena, Emilia - Romagna, 41124, Italy|U.O. Oncologia Medica 1 - AOU Pisana, Pisa, Tuscany, 56126, Italy|Azienda Ospedaliera "Spedali Civili di Brescia", Brescia, 25123, Italy|Azienda Ospedaliera Universitaria Careggi, Florence, 50134, Italy|Istituto Europeo di Oncologia, Milano, 20141, Italy Less << |
NCT01997255 | Sturge Weber Syndrome | PHASE2 | WITHDRAWN | 2025-04-16 | Texas Children's Hospital, Hou... More >>ston, Texas, 77030, United States Less << |
NCT01324492 | Lung Neuroendocrine Neoplasm | PHASE1 | COMPLETED | 2025-06-14 | Novartis Investigative Site, B... More >>eijing, Beijing, 100730, China|Novartis Investigative Site, Guangzhou, Guangdong, 510030, China|Novartis Investigative Site, Changchun, Jilin, China|Novartis Investigative Site, Shenyang, Liaoning, China Less << |
NCT00124280 | Non-small-cell Lung Carcinoma | PHASE2 | COMPLETED | - | Nevada Cancer Institute, Las V... More >>egas, Nevada, 89135, United States|MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology, Houston, Texas, 77030, United States Less << |
NCT00081874 | Leukemia|Mantle Cell Lymphoma|... More >>Myelofibrosis Less << | PHASE1|PHASE2 | COMPLETED | 2025-09-06 | M.D. Anderson Cancer Center, H... More >>ouston, Texas, 77030, United States Less << |
NCT00767819 | Progressive Sarcoma | PHASE2 | COMPLETED | 2017-05-17 | Novartis Investigative Site, B... More >>ad Saarow, 15526, Germany|Novartis Investigative Site, Duesseldorf, 40479, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Mannheim, 68167, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Milano, MI, 20133, Italy Less << |
NCT02205515 | Carcinoma, Neuroendocrine | PHASE1|PHASE2 | COMPLETED | 2025-10-21 | Odette Cancer Centre, Sunnybro... More >>ok Health Science Centre, Toronto, Ontario, M4N 3M5, Canada Less << |
NCT00373815 | Graft Versus Host Disease | PHASE1 | TERMINATED | 2025-10-09 | Medical Center, Hematology & O... More >>ncology, University of Tuebingen, Tuebingen, D-72076, Germany Less << |
NCT01206764 | Renal Cell Carcinoma | PHASE4 | COMPLETED | 2017-07-01 | Novartis Investigative Site, A... More >>lger, 016000, Algeria|Novartis Investigative Site, Oran, Algeria|Novartis Investigative Site, Alexandria, 21131, Egypt|Novartis Investigative Site, Cairo, Egypt|Novartis Investigative Site, Mansoura, Egypt|Novartis Investigative Site, Indore, Madhya Pradesh, 452 008, India|Novartis Investigative Site, Pune, Maharashtra, 411013, India|Novartis Investigative Site, Amman, 11941, Jordan|Novartis Investigative Site, Ashrafieh, 166830, Lebanon|Novartis Investigative Site, Moscow, 115478, Russian Federation|Novartis Investigative Site, Samara, 443031, Russian Federation|Novartis Investigative Site, Riyadh, 11211, Saudi Arabia|Novartis Investigative Site, Cape Town, 7500, South Africa|Novartis Investigative Site, Cape Town, 7925, South Africa|Novartis Investigative Site, Durban, 4001, South Africa|Novartis Investigative Site, Parktown, 2193, South Africa|Novartis Investigative Site, Songkhla, Hat Yai, 90110, Thailand|Novartis Investigative Site, Bangkok, 10400, Thailand|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Tunis, Tunisie, 1007, Tunisia|Novartis Investigative Site, Ariana, 2080, Tunisia|Novartis Investigative Site, Sousse, 4000, Tunisia Less << |
NCT02539459 | Sporadic Angiomyolipomas (AMLs... More >>) Less << | PHASE2 | TERMINATED | 2018-08-20 | Yale School of Medicine, New H... More >>aven, Connecticut, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Memorial Sloan Kettering, New York, New York, United States|Duke University Health System, Durham, North Carolina, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|M D Anderson Cancer Center, Houston, Texas, United States Less << |
NCT00688753 | Carcinoma|Renal Cell|Non Clear... More >> Cell Renal Carcinoma|Papillary Cell Renal Carcinoma|Adenocarcinoma Less << | PHASE2 | COMPLETED | 2025-10-14 | Novartis Investigative Site, B... More >>russels, BE-B-1200, Belgium|Novartis Investigative Site, Gent, 9000, Belgium|Novartis Investigative Site, Bordeaux Cedex, 33075, France|Novartis Investigative Site, Lyon Cedex, 69373, France|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Paris, 75015, France|Novartis Investigative Site, Villejuif Cedex, 94805, France|Novartis Investigative Site, Berlin, 10098, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Arezzo, AR, 52100, Italy|Novartis Investigative Site, Cremona, CR, 26100, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Napoli, 80132, Italy|Novartis Investigative Site, Otwock, 05-400, Poland|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalu?a, 08907, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46009, Spain|Novartis Investigative Site, Barcelona, 08041, Spain Less << |
NCT01490476 | Neurofibromatosis 2 | PHASE2 | COMPLETED | 2025-01-17 | H?pital Beaujon, 100 boulevard... More >> du Général Leclerc, Clichy, 92110, France Less << |
NCT00519324 | Advanced Gastric Cancer | PHASE2 | COMPLETED | - | Novartis investigative Site, A... More >>ichi, Japan|Novartis investigative Site, Chiba, Japan|Novartis investigative Site, Ehime, Japan|Novartis Investigative Site, Hokkaido, Japan|Novartis investigative Site, Osaka, Japan|Novartis investigative Site, Shizuoka, Japan|Novartis Investigative Site, Tochigi, Japan|Novartis investigative Site, Tokyo, Japan Less << |
NCT01880749 | Neurofibromatosis Type 2|Vesti... More >>bular Schwannomas|Meningiomas Less << | EARLY_PHASE1 | COMPLETED | 2025-12-19 | New York University School of ... More >>Medicine, New York, New York, 10016, United States Less << |
NCT03525834 | Renal Angiomyolipoma | PHASE4 | COMPLETED | 2020-09-25 | Novartis Investigative Site, W... More >>uhan, Hubei, 430030, China|Novartis Investigative Site, Shanghai, Shanghai, 200032, China|Novartis Investigative Site, Chengdu, Sichuan, 610041, China|Novartis Investigative Site, Beijing, 100028, China|Novartis Investigative Site, Beijing, 100730, China Less << |
NCT01178151 | Peutz-Jeghers Syndrome|Neoplas... More >>tic Processes|Neoplasm Metastasis Less << | PHASE2 | WITHDRAWN | 2025-04-15 | Academic Medical Center, Amste... More >>rdam, 1105AZ, Netherlands|Erasmus Medical Center, Rotterdam, 3000 CA, Netherlands Less << |
NCT02812940 | Graft-versus-Host Disease | PHASE2 | COMPLETED | 2025-12-20 | University of Cologne, Cologne... More >>, 50924, Germany Less << |
NCT00457964 | Tuberous Sclerosis|Lymphangiol... More >>eiomyomatosis Less << | PHASE1|PHASE2 | COMPLETED | 2025-07-13 | Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less << |
NCT01631058 | Chronic Renal Failure (CRF)|Gr... More >>aft Failure|Transplant; Failure, Kidney|Renal Transplant Rejection Less << | PHASE4 | UNKNOWN | 2025-06-19 | Clinical Hospital of the Schoo... More >>l of Medicine, University of Sao Paulo, Sao Paulo, SP, 05403900, Brazil|Clinical Hospital of the School of Medicine, University of Sao Paulo, Sao Paulo, SP, 05403900, Brazil Less << |
NCT00170820 | Renal Transplantation | PHASE4 | COMPLETED | - | Novartis, Basel, Switzerland |
NCT01715935 | Clear-cell Renal Carcinoma|Cle... More >>ar-cell Metastatic Renal Cell Carcinoma Less << | PHASE2 | COMPLETED | 2025-04-16 | CHRU Besan?on, Besan?on, 25000... More >>, France|H?pital Henri Mondor, Créteil, 94000, France|Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, 85925 cedex 9, France|H?pital Saint Eloi - CHU Montpellier, Montpellier, 34285 cedex 5, France|F?pital d'Instruction des Amées du Val de Grace, Paris, 75005, France|H?pital Cochin, Paris, 75014, France|H?pital Européen Georges Pompidou - Service d'oncologie médicale, Paris, 7505, France|Institut de Cancérologie Lucien Neuwirth, Saint Priest en Jarez, 42270, France|Centre Alexis Vautrin, Vandoeuvre-lès-nancy, 54511, France|Institut Gustave Roussy, Villejuif, 94805 cedex, France Less << |
NCT00436618 | Leukemia|Lymphoma|Lymphoprolif... More >>erative Disorder Less << | PHASE2 | COMPLETED | 2019-10-09 | Mayo Clinic Scottsdale, Scotts... More >>dale, Arizona, 85259-5499, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, 32224, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, 55905, United States Less << |
NCT00973713 | Cholangiocarcinoma | PHASE2 | UNKNOWN | 2025-03-12 | Austin Health, Melbourne, Vict... More >>oria, 3084, Australia Less << |
NCT05252585 | Renal Angiomyolipoma | PHASE4 | RECRUITING | 2026-02-21 | Novartis Investigative Site, T... More >>aichung, Taiwan ROC, 40201, Taiwan|Novartis Investigative Site, Taoyuan, Taiwan ROC, 33305, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan Less << |
NCT01242631 | Testicular Cancer|Germ Cell Ca... More >>ncer Less << | PHASE2 | COMPLETED | 2025-03-14 | Vivantes Klinikum am Urban, Be... More >>rlin, 10967, Germany|Universitatsklinikum Essen, Essen, 45122, Germany|Universitatsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Hannover Medical School, Hannover, 30625, Germany|Universitatsklinikum Schieswig-Holstein - Campus Kiel, Kiel, 24105, Germany|Universitatsklinikum Marburg, Marburg, 35043, Germany|Klinikum Harlaching München, München, 81545, Germany|Universitatsklinikum der Eberhard-Karls-Universitat Tübingen, Tübingen, 72076, Germany Less << |
NCT01931163 | Breast Cancer|Triple Negative ... More >>Breast Cancer Less << | PHASE2 | COMPLETED | 2025-01-19 | The Methodist Hospital, Housto... More >>n, Texas, 77030, United States|Houston Methodist Hospital Willowbrook, Houston, Texas, 77070, United States|Houston Methodist Hospital Sugar Land, Sugar Land, Texas, 77479, United States Less << |
NCT06126588 | Meningioma | PHASE2 | NOT_YET_RECRUITING | 2028-05-01 | CHRU of Nancy, Vand?uvre-lès-N... More >>ancy, Grand Est, 54511, France|Nancy Hospital, Vand?uvre-lès-Nancy, 54511, France Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.04mL 0.21mL 0.10mL |
5.22mL 1.04mL 0.52mL |
10.44mL 2.09mL 1.04mL |